NCT06295861
Prospective Cohort Study of Panvascular Disease in China(PAN-China)
StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Enrollment reopened Show 6 more changesShow less
- Eligibility criteria expanded, about 129 words
- Trial arms changed: 2 → 3
- Study sites: 2 to 3
- Study description expanded, about 486 words
- Collaborators expanded, about 80 words
- Study title expanded, about 2 words
- Notable Changed Sponsor changed: Second Affiliated Hospital, School of Medicine, Zhejiang University to Second Affiliated Hospital, Zhejiang University, School of Medicine
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Cardiovascular adverse events
Timeframe: 1, 3, and 5 years follow-up
Cardiovascular mortality
Timeframe: 1, 3, and 5 years follow-up
Secondary (2)
Rate of receiving vascular revascularization
Readmission rate for vascular reasons
Arms and interventions
Patients with panvascular disease cohort
The patient had atherosclerosis in 2 or more vessels
Patients with single disease cohort
The patient had atherosclerosis in 1 vessel
High risk cohort
individuals at high risk of ASCVD or suffering from metabolic syndrome
Other: no different intervention between the two cohort.
Sites
3 sites in 1 country